Vitabrid Japan establishes a direct marketing business
First written in FY2018-Q1. 29 of 39 entries say "Advanced", first in FY2018-Q2. Latest entry: 2026-10-15.
No other company in this theme has enough history to compare yet.
- FY2027-H1AdvancedAnnual report
「In the direct marketing business, the company worked to strengthen sales of existing products while developing new products, taking advertising efficiency into account. In this context, at Vitabrid Japan Inc., the number of new customers increased through efficient advertising investment, the continuing customer base expanded, and distribution through drugstores, various e-commerce marketplaces and channels outside the company's own e-commerce sites, including television shopping, also expanded. In addition, sales of the Brighte SHOWER DRYER at 株式会社Japan entry, which wholesales beauty appliances, remained strong. As a result, revenue reached a record high for a quarterly accounting period and gross profit reached a record high for a second-quarter accounting period. Although advertising investment was accelerated in the second quarter, it did not absorb the unspent portion from the first quarter, and the business finished above its revised first-half operating profit plan. As a result, revenue in the direct marketing business was ¥9,099 million, up 21.9% year on year, and operating profit was ¥492 million, compared with an operating loss of ¥126 million in the same interim period of the previous year.」
The company strengthened sales of existing products, developed new products, invested efficiently in advertising, and expanded its continuing customer base and channels outside its own e-commerce sites, generating revenue of ¥9,099 million and operating profit of ¥492 million. It returned to profitability from an operating loss in the previous year, while revenue and gross profit also reached record highs. - FY2026AdvancedAnnual report
「In the direct marketing business operated by Vitabrid Japan Inc. and others, the company worked to strengthen sales of existing products and develop new products while taking advertising efficiency into account. By controlling advertising investment while monitoring market conditions, it achieved record revenue and gross profit.」
By strengthening sales of existing products, developing new products and controlling advertising investment, the direct marketing business achieved record revenue and gross profit, while operating profit increased 52.2% year on year. - 2026-04-14AdvancedRevision of earnings forecasts
「Vitabrid Japan Inc. was newly listed on the Growth Market of the Tokyo Stock Exchange on 2 April 2026.」
Vitabrid Japan Inc. was successfully newly listed on the Growth Market of the Tokyo Stock Exchange. - FY2026-H1AdvancedAnnual report
「In the direct marketing business, the company worked to boost sales of existing products while developing new products, taking advertising efficiency into account. By controlling advertising investment while monitoring market conditions, it achieved record sales volume and revenue for the second quarter. Operating profit increased because advertising and sales promotion expenses were kept under control with a focus on advertising efficiency. Vitabrid Japan Inc. also set a new monthly sales record in August 2025.」
The company controlled investment with a focus on advertising efficiency, while strengthening sales of existing products and developing new products. Second-quarter sales volume and revenue, as well as Vitabrid Japan Inc.'s monthly revenue in August 2025, reached record highs. - FY2025Record revenue, lower profitAnnual report
「Revenue in the direct marketing business was ¥13,520 million, up 5.3% year on year, while operating profit was ¥747 million, down 35.4%.」
After reducing promotional investment in the first quarter in response to changes in consumer sentiment toward foods with function claims, the company accelerated investment from the middle of the second quarter. Revenue reached a record high, while full-year operating profit declined. - FY2025-H1Operating loss widens despite renewed acceleration of promotional investmentAnnual report
「In the direct marketing business operated by Vitabrid Japan Inc. and others, promotional investment was reduced in the first quarter based on new customer acquisition efficiency, in light of changes in consumer sentiment toward foods with function claims following the supplement-related health problems caused by red yeast rice ingredients at another company. The issue had improved by the middle of the second quarter, and accelerated promotional investment led to steady sales of the Terminalia First supplement. Revenue was therefore broadly in line with the previous year.」
After reducing promotional investment in the first quarter, the company accelerated investment from the middle of the second quarter. Sales of the Terminalia First supplement were steady, but revenue for the business as a whole was ¥5,927 million and the operating loss widened to ¥510 million from ¥143 million in the same period of the previous year. Development of the functional supplement containing GABA and other ingredients also continued. - FY2025-Q1Reduced advertising investment and lower profitAnnual report
「In the direct marketing business operated by Vitabrid Japan Inc. and others, the company worked to develop new products. At the same time, in light of changes in consumer sentiment toward foods with function claims following the recent issue of supplement-related health problems caused by red yeast rice ingredients at another company, it reduced advertising investment based on the efficiency of new customer acquisition. Revenue declined due to a temporary increase in cancellations of supplement products and the impact of the transfer of shares in one subsidiary carried out in the third quarter of the previous fiscal year. Profit also declined, mainly because lower advertising investment reduced supplement product revenue and related profit.」
Advertising investment was reduced in light of changes in consumer sentiment toward foods with function claims, and revenue and profit declined amid a temporary increase in cancellations. The company has also indicated a policy of actively increasing advertising expenses from the second quarter onward. - FY2024AdvancedAnnual report
「In the direct marketing business operated by Vitabrid Japan Inc. and others, advertising investment was curtailed and new customer acquisition was temporarily restrained during the first quarter based on customer acquisition efficiency. In addition, the company transferred the shares of Direct Tech during the third quarter. As a result, revenue declined, but operating profit reached a record high.」
Revenue fell to ¥12,912 million due to reduced advertising investment and the transfer of Direct Tech shares, while operating profit reached a record high of ¥1,006 million. - FY2024-Q3WorsenedAnnual report
「In the direct marketing business operated by Vitabrid Japan Inc. and others, advertising investment was curtailed and new customer acquisition was temporarily restrained during the first quarter based on customer acquisition efficiency, resulting in lower revenue and profit for the nine months ended the third quarter. The company also worked to develop new products and began selling a functional supplement containing GABA and other ingredients in September 2023. For the fiscal year, it expects to secure operating profit in line with its earnings forecast while focusing on developing new products. As a result, revenue in the direct marketing business was ¥9,935 million, down 11.0% year on year, and the operating loss was ¥189 million, compared with operating profit of ¥645 million in the same period of the previous year.」
Advertising investment was curtailed and new customer acquisition was temporarily restrained, resulting in cumulative revenue down 11.0% year on year and a deterioration from operating profit to an operating loss of ¥189 million. Meanwhile, the company launched a functional supplement in September 2023 and is continuing to develop the new product. - FY2024-Q2AdvancedAnnual report
「The company also worked to develop new products and began selling a functional supplement containing GABA and other ingredients in September 2023. For the fiscal year, it expects to secure operating profit in line with its earnings forecast while continuing advertising investment based on customer acquisition efficiency and focusing on developing new products.」
The direct marketing business launched a functional supplement containing GABA and other ingredients in September 2023 and is pursuing customer acquisition based on advertising efficiency while developing new products. First-half revenue was ¥6,684 million and the operating loss was ¥237 million. - FY2023AdvancedAnnual report
「In the direct marketing business operated by Vitabrid Japan Inc. and others, continued advertising investment from the beginning of the period enabled the acquisition of more new customers than planned. Sales of the Terminalia First supplement remained strong, and full-year revenue and operating profit both reached record highs.」
Continued advertising investment generated more new customers than planned, resulting in record full-year revenue of ¥14,691 million and operating profit of ¥984 million. - FY2023-Q3AdvancedAnnual report
「In the direct marketing business operated by Vitabrid Japan Inc. and others, continued advertising investment from the beginning of the fiscal year resulted in more new customers being acquired than planned. Sales of “ターミナリアファースト” progressed favorably, and the business set new records for quarterly consolidated net sales and operating profit.」
Continued advertising investment generated more new customers than planned, and quarterly revenue and operating profit reached record highs. Cumulative revenue was ¥11,162 million and operating profit was ¥645 million. - FY2023-Q2Continued advertising investment and record sales, but an operating lossAnnual report
「In the direct marketing business operated by Vitabrid Japan Inc. and others, continued advertising investment from the beginning of the period enabled the acquisition of more new customers than planned. Sales of the Terminalia First supplement remained strong, and quarterly revenue reached a record high.」
The direct marketing business acquired more new customers than planned through continued advertising investment, and quarterly revenue reached a record high. However, the cumulative operating loss for the first half was ¥86 million. - FY2023-Q1AdvancedAnnual report
「Strategically investing a substantial advertising budget as planned at the beginning of the period enabled the company to acquire more new customers than planned, resulting in record revenue for the first quarter. However, the substantial advertising investment temporarily pushed the business into an operating loss. As a result, revenue in the direct marketing business was ¥3,502 million, up 19.1% year on year, while the operating loss was ¥177 million, compared with operating profit of ¥298 million in the same quarter of the previous year.」
Strategic advertising investment generated more new customers than planned, resulting in record revenue for the first quarter. However, the front-loading of advertising expenses resulted in an operating loss of ¥177 million. - FY2022AdvancedAnnual report
「The impact of actively investing in advertising during the third quarter became evident in the direct marketing business. In the fourth quarter, the number of newly acquired customers increased, quarterly revenue reached a record high, and full-year revenue and operating profit also reached record highs.」
Active advertising investment increased the number of new customers, resulting in record full-year revenue of ¥12,326 million and operating profit of ¥774 million. - FY2022-Q3WorsenedAnnual report
「Compared with the first six months of the previous fiscal year, when the direct marketing business operated by Vitabrid Japan Inc. and others made substantial advertising and promotional expenditures in response to stay-at-home demand during the COVID-19 pandemic, the business temporarily restrained new customer acquisition through the second quarter of the current fiscal year by investing in advertising and promotion based on acquisition efficiency. However, it resumed aggressive advertising and promotional spending from the third quarter to increase new customer acquisitions. As a result, net sales in the direct marketing business were ¥8,709 million, down 0.6% year on year, and operating profit was ¥432 million, down 36.6%.」
As a result of ramping up advertising spending again from the third quarter, the company sought to increase new customer acquisitions, but revenue declined slightly and operating profit fell 36.6% year on year. - FY2022-Q2AdvancedAnnual report
「Compared with the first six months of the previous fiscal year, when the direct marketing business operated by Vitabrid Japan Inc. and others made substantial advertising and promotional expenditures in response to stay-at-home demand during the COVID-19 pandemic, the business temporarily restrained new customer acquisition in the first six months of the current fiscal year by investing in advertising and promotion based on acquisition efficiency. However, sales of the “Vitabrid C” series progressed steadily, mainly among existing customers, so net sales declined only slightly while operating profit increased substantially. For the consolidated fiscal year, the company expects business to continue progressing steadily as it accelerates advertising and promotional spending from the third quarter onward, increasing new customer acquisitions and implementing sales initiatives through effective marketing. As a result, net sales in the direct marketing business were ¥5,815 million, down 0.3% year on year, and operating profit was ¥559 million, up 810.3%.」
The company significantly increased profit while temporarily restraining new-customer acquisition based on advertising efficiency, generating operating income of ¥559 million. It also indicated that customer acquisition would be expanded by accelerating advertising spending from the third quarter onward. - FY2022-Q1AdvancedAnnual report
「In the direct marketing business operated by Vitabrid Japan Inc. and other companies, advertising and promotional spending based on the efficiency of acquiring new customers supported steady sales of the Vitabrid C series. The business achieved record revenue for a first-quarter cumulative period in the three-month period ended the first quarter. As a result, the direct marketing business generated revenue of ¥2,940 million, up 6.1% year on year, and operating income of ¥298 million, compared with an operating loss of ¥509 million in the same quarter of the previous year.」
Advertising and promotional spending based on the efficiency of acquiring new customers drove revenue to a record high, while operating income improved from an operating loss in the same period of the previous year to ¥298 million. - FY2021AdvancedAnnual report
「In the direct marketing business, the company strategically allocated a substantial advertising budget during the first-quarter consolidated accounting period based on increased stay-at-home demand resulting from restrictions on going out following the declaration of a state of emergency, as well as the efficiency of acquiring new customers. As a result, it acquired more new customers than planned, and the direct marketing business achieved record revenue and operating income for the consolidated fiscal year.」
The strategic allocation of the advertising budget in the first quarter resulted in more new customers than planned, producing record full-year revenue of ¥11,389 million and operating income of ¥716 million. - FY2021-Q3AdvancedAnnual report
「In the direct marketing business operated by Vitabrid Japan Inc. and other companies, the company strategically allocated a substantial advertising budget during the first-quarter consolidated accounting period to maximize revenue and profit throughout the year, based on increased stay-at-home demand amid the COVID-19 pandemic and the efficiency of acquiring new customers. As a result, it acquired more new customers than planned, and operating income in the third-quarter consolidated accounting period reached a record ¥619 million, following the second-quarter consolidated accounting period.」
The advertising budget allocated in the first quarter resulted in more new customers than planned, and operating income in the third-quarter accounting period reached a record ¥619 million. Cumulative revenue was ¥8,760 million and operating income was ¥681 million. - FY2021-Q2AdvancedAnnual report
「In the direct marketing business operated by Vitabrid Japan Inc. and other companies, the company strategically allocated a substantial advertising budget during the first-quarter consolidated accounting period to maximize revenue and profit throughout the year, based on increased stay-at-home demand amid the COVID-19 pandemic and the efficiency of acquiring new customers. As a result, it acquired more new customers than planned and recorded record revenue of ¥3,059 million and operating income of ¥571 million in the second-quarter consolidated accounting period.」
The strategic allocation of the advertising budget in the first quarter resulted in more new customers than planned, producing record revenue of ¥3,059 million and operating income of ¥571 million in the second-quarter accounting period. Cumulatively, revenue was ¥5,830 million and operating income was ¥61 million. - FY2021-Q1AdvancedAnnual report
「Based on increased stay-at-home demand amid the COVID-19 pandemic and the efficiency of acquiring new customers, the company strategically allocated a substantial advertising budget during the first-quarter consolidated accounting period and acquired more new customers than planned.」
The strategic early allocation of the advertising budget resulted in more new customers than planned, and the direct marketing business recorded record revenue of ¥2,771 million. However, front-loaded advertising expenses resulted in an operating loss of ¥509 million. - FY2020AdvancedAnnual report
「In the direct marketing business, effective and efficient advertising and promotional activities kept sales of Vitabrid Japan Inc.'s mainstay Vitabrid C product strong throughout the year, resulting in higher revenue and profit year on year.」
The direct marketing business generated revenue of ¥8,537 million and operating income of ¥557 million, up 31.0% and 21.6% year on year, respectively, through efficient advertising and promotional activities. - FY2020-Q3WorsenedAnnual report
「In the direct marketing business operated by Vitabrid Japan Inc., sales of the company's Vitabrid C product were strong and revenue continued to perform steadily. However, operating income declined year on year in the third-quarter consolidated accounting period because the company increased advertising spending on new products to achieve further earnings growth. As a result, the direct marketing business generated revenue of ¥6,306 million, up 43.0% year on year, and operating income of ¥304 million, down 6.8%.」
Advertising spending on new products drove revenue up 43.0% year on year, while operating income declined 6.8%. - FY2020-Q2AdvancedAnnual report
「In the direct marketing business operated by Vitabrid Japan Inc., sales of the company's Vitabrid C product were strong, achieving revenue growth of more than 40% year on year. The company also generated substantial profit by conducting more efficient advertising and promotional activities. As a result, the direct marketing business generated revenue of ¥4,150 million, up 46.0% year on year, and operating income of ¥380 million, up 223.4%.」
The direct marketing business generated revenue of ¥4,150 million, up 46.0% year on year, and operating income of ¥380 million, up 223.4%. Efficient advertising and promotional activities led to a substantial increase in profit from the same period of the previous year. - FY2020-Q1AdvancedAnnual report
「In the direct marketing business operated by Vitabrid Japan Inc., sales of the company's Vitabrid C product were strong, achieving revenue growth of more than 70% from the previous consolidated fiscal year. Although the company recorded a loss in the same period of the previous year because it concentrated advertising and promotional spending, it generated substantial profit during the period by conducting more efficient advertising and promotional activities. As a result, the direct marketing business generated revenue of ¥2,121 million, up 73.6% year on year, and operating income of ¥175 million, compared with an operating loss of ¥153 million in the same period of the previous year.」
Sales of Vitabrid C generated revenue of ¥2,121 million, up 73.6% year on year, and efficient advertising and promotional activities resulted in a shift from an operating loss of ¥153 million in the same period of the previous year to operating income of ¥175 million. - FY2019AdvancedAnnual report
「In the direct marketing business operated by Vitabrid Japan Inc., sales of the company's Vitabrid C product were strong, achieving revenue growth of more than 130% from the previous consolidated fiscal year. Although the company recorded a loss in the first quarter because it concentrated advertising and promotional spending at the beginning of the fiscal year, operating income for the full year grew by more than 110% from the previous consolidated fiscal year, partly due to the effects of advertising. As a result, the direct marketing business generated revenue of ¥6,519 million, up 128.7% year on year, and operating income of ¥458 million, up 113.3%.」
The business recovered from its first-quarter operating loss, generating full-year revenue of ¥6,519 million and operating income of ¥458 million. Revenue increased 128.7% and operating income increased 113.3%. - FY2019-Q3AdvancedAnnual report
「In the direct marketing business operated by Vitabrid Japan Inc., sales of the company's Vitabrid C product were strong, achieving revenue growth of more than 130% year on year. Although the company recorded a loss in the first quarter because it concentrated advertising and promotional spending at the beginning of the fiscal year, operating income for the nine-month period ended the third quarter grew by more than 80% year on year, partly due to the effects of advertising. As a result, the direct marketing business generated revenue of ¥4,410 million, up 124.3% year on year, and operating income of ¥327 million, up 86.1%.」
The business recovered from its first-quarter operating loss and remained profitable, with operating income of ¥327 million for the nine-month period ended the third quarter. Revenue was ¥4,410 million, up 124.3% year on year, and operating income was up 86.1%. - FY2019-Q2AdvancedAnnual report
「In the direct marketing business operated by Vitabrid Japan Inc., sales of the company's Vitabrid C product were strong, achieving revenue growth of more than 110% year on year. The company recorded a loss in the first quarter because it concentrated advertising and promotional spending at the beginning of the fiscal year, but returned to profitability in the six-month period ended the second quarter as the effects of its advertising emerged. As a result, the direct marketing business generated revenue of ¥2,842 million, up 117.5% year on year, and operating income of ¥117 million, down 3.0% year on year.」
The business returned to profitability, moving from an operating loss of ¥153 million in the first quarter to operating income of ¥117 million for the six-month period ended the second quarter. Revenue was also ¥2,842 million, up 117.5% year on year. - FY2019-Q1WorsenedAnnual report
「In the direct marketing business operated by Vitabrid Japan Inc., sales of the company's Vitabrid C product were strong, achieving growth of more than 80% year on year in revenue. However, as the company invested aggressively in advertising and promotional expenses during the nine-month period ended the first quarter, it recorded an operating loss. As a result, the direct marketing business generated revenue of ¥1,221 million, up 84.7% year on year, and an operating loss of ¥153 million, compared with operating income of ¥71 million in the same period of the previous year.」
Revenue from Vitabrid C increased 84.7% year on year, while aggressive advertising spending resulted in an operating loss of ¥153 million, a deterioration from operating income of ¥71 million in the same period of the previous year. The company said the business would perform steadily for the full year as the effects of advertising and marketing took hold. - FY2018AdvancedAnnual report
「In the direct marketing business operated by Vitabrid Japan Inc., sales of the company's Vitabrid C product were strong, and the company promoted online sales based on efficient marketing. The business continued to perform steadily. As a result, the direct marketing business generated revenue of ¥2,850 million and operating income of ¥214 million.」
Online sales of Vitabrid C continued, generating revenue of ¥2,850 million and operating income of ¥214 million in the direct marketing business. - FY2018-Q3AdvancedAnnual report
「In the direct marketing business operated by Vitabrid Japan Inc., which became a consolidated subsidiary from an equity-method affiliate in December 2016, sales of the company's Vitabrid C product were strong. The company promoted online sales based on efficient marketing, and the business continued to perform steadily. As a result, the direct marketing business generated revenue of ¥1,966 million and operating income of ¥175 million.」
Sales of Vitabrid C and efficient online sales continued, generating cumulative revenue of ¥1,966 million and operating income of ¥175 million in the direct marketing business. - FY2018-Q2AdvancedAnnual report
「In the direct marketing business operated by Vitabrid Japan Inc., which became a consolidated subsidiary from an equity-method affiliate in December 2016, sales of the company's Vitabrid C product were strong, and the business performed steadily overall under an efficient online marketing operating structure. As a result, the direct marketing business generated revenue of ¥1,307 million and operating income of ¥121 million.」
Sales of Vitabrid C remained strong, and under an efficient online marketing operating structure, cumulative revenue was ¥1,307 million and operating income was ¥121 million. - FY2018-Q1First statedAnnual report
「In the direct marketing business operated by Vitabrid Japan Inc., which became a consolidated subsidiary from an equity-method affiliate in December 2016, sales of the company's Vitabrid C product were strong. Although advertising expenses increased, the company established an efficient marketing operating structure for online sales, and the business performed steadily overall. As a result, the direct marketing business generated revenue of ¥661 million and operating income of ¥71 million.」
Following the consolidation of Vitabrid Japan Inc. as a subsidiary, sales of Vitabrid C, the efficient online marketing operating structure and revenue of ¥661 million and operating income of ¥71 million were identified as new business themes.